{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:35Z","timestamp":1786979615621,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00108-026-02056-x","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:53:24Z","timestamp":1771325604000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Funktionelles Assessment und Medikation im h\u00f6heren Lebensalter","Functional assessment and medication in older adults"],"prefix":"10.1007","volume":"67","author":[{"given":"M. Cristina","family":"Polidori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornel","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2056_CR1","unstructured":"EMA\/CHMP Reflection paper on the pharmaceutical management in older patients (2023). www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-pharmaceutical-development-medicines-use-older-population-first-version_en.pdf"},{"issue":"12","key":"2056_CR2","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.3390\/ijerph15122843","volume":"15","author":"G Liotta","year":"2018","unstructured":"Liotta\u00a0G et\u00a0al (2018) Frailty as the Future Core Business of Public Health: Report of the Activities of the A3 Action Group of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Int J Environ Res Public Health 15(12):2843\u20132843. https:\/\/doi.org\/10.3390\/ijerph15122843","journal-title":"Int J Environ Res Public Health"},{"key":"2056_CR3","doi-asserted-by":"publisher","unstructured":"Dent et\u00a0al (2019) Management of frailty: opportunities, challenges, and future directions. Lancet 394(10206):1376\u20131386. https:\/\/doi.org\/10.1016\/S0140-6736(19)31785-4","DOI":"10.1016\/S0140-6736(19)31785-4"},{"issue":"10206","key":"2056_CR4","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk\u00a0EO, Afilalo\u00a0J, Ensrud\u00a0KE, Kowal\u00a0P, Onder\u00a0G, Fried\u00a0LP (2019) Frailty: implications for clinical practice and public health. Lancet 394(10206):1365\u20131375","journal-title":"Lancet"},{"issue":"1","key":"2056_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41572-022-00376-4","volume":"8","author":"ST Skou","year":"2022","unstructured":"Skou\u00a0ST et\u00a0al (2022) Multimorbidity. Nat Rev Dis Primers 8(1):48. https:\/\/doi.org\/10.1038\/s41572-022-00376-4","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2056_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","volume":"391","author":"DH Kim","year":"2024","unstructured":"Kim\u00a0DH, Rockwood\u00a0K (2024) Frailty in Older Adults. N Engl J Med 391(6):538\u2013548. https:\/\/doi.org\/10.1056\/NEJMra2301292","journal-title":"N Engl J Med"},{"issue":"9","key":"2056_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/a-2360-2794","volume":"150","author":"MC Polidori","year":"2025","unstructured":"Polidori\u00a0MC, Denkinger\u00a0M (2025) Multimorbidit\u00e4t \u2013 nur gemeinsam l\u00f6sbar. Dtsch Med Wochenschr 150(9):463\u2013464. https:\/\/doi.org\/10.1055\/a-2360-2794","journal-title":"Dtsch Med Wochenschr"},{"issue":"1-02","key":"2056_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/a-2033-4757","volume":"149","author":"JM Bauer","year":"2024","unstructured":"Bauer\u00a0JM, Denkinge\u00a0M, Polidori\u00a0MC, Sieber\u00a0C, Wirth\u00a0R (2024) Frailty-Management \u2013 jetzt! [Frailty management - now!]. Dtsch Med Wochenschr 149(1-02):1\u20132. https:\/\/doi.org\/10.1055\/a-2033-4757","journal-title":"Dtsch Med Wochenschr"},{"key":"2056_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1055\/s-0041-109330","volume":"140","author":"CC Sieber","year":"2015","unstructured":"Sieber\u00a0CC (2015) Welche medizinische Evidenz ist im Alter ad\u00e4quat? Joints 140:1795\u20131796. https:\/\/doi.org\/10.1055\/s-0041-109330","journal-title":"Dtsch Med Wochenschr"},{"issue":"1-02","key":"2056_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/a-2033-4924","volume":"149","author":"MC Polidori","year":"2024","unstructured":"Polidori\u00a0MC, Sieber\u00a0C (2024) Frailty: Pr\u00e4vention [Frailty: Prevention]. Dtsch Med Wochenschr 149(1-02):15\u201322. https:\/\/doi.org\/10.1055\/a-2033-4924","journal-title":"Dtsch Med Wochenschr"},{"issue":"1-02","key":"2056_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/a-2033-4924","volume":"149","author":"MC Polidori","year":"2024","unstructured":"Polidori\u00a0MC, Sieber\u00a0C (2024) Frailty: Pr\u00e4vention [Frailty: Prevention]. Dtsch Med Wochenschr 149(1-02):15\u201322. https:\/\/doi.org\/10.1055\/a-2033-4924","journal-title":"Dtsch Med Wochenschr"},{"issue":"7","key":"2056_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jep.70283","volume":"31","author":"NN Ngcobo","year":"2025","unstructured":"Ngcobo\u00a0NN (2025) Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions. J\u00a0Eval Clin Pract 31(7):e70283. https:\/\/doi.org\/10.1111\/jep.70283","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"2056_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4235\/agmr.24.0034","volume":"28","author":"S Thanapluetiwong","year":"2024","unstructured":"Thanapluetiwong\u00a0S, Chattaris\u00a0T, Shi\u00a0SM, Park\u00a0CM, Sison\u00a0SDM, Kim\u00a0DH (2024) Association between Drug Therapy and Risk of Incident Frailty: A Systematic Review. Ann Geriatr Med Res 28(3):247\u2013256. https:\/\/doi.org\/10.4235\/agmr.24.0034","journal-title":"Ann Geriatr Med Res"},{"key":"2056_CR14","volume-title":"Geriatrie","author":"JM Bauer","year":"2024","unstructured":"Bauer\u00a0JM, Becker\u00a0C, Denkinger\u00a0M, Wirth\u00a0R (2024) Geriatrie. W. Kohlhammer GmbH"},{"issue":"5","key":"2056_CR15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/jgs.18684","volume":"72","author":"SL Gray","year":"2024","unstructured":"Gray\u00a0SL, Brandt\u00a0N, Schmader\u00a0KE, Hanlon\u00a0JT (2024) Medication use quality and safety in older adults: 2022 update. J\u00a0Am Geriatr Soc 72(5):1329\u20131337. https:\/\/doi.org\/10.1111\/jgs.18684","journal-title":"J Am Geriatr Soc"},{"key":"2056_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00108-025-01986-2","volume":"66","author":"C Sieber","year":"2025","unstructured":"Sieber\u00a0C (2025) Frailty und Intrinsic Capacity. Inn Med 66:1007\u20131008. https:\/\/doi.org\/10.1007\/s00108-025-01986-2","journal-title":"Innere Medizin"},{"issue":"1-02","key":"2056_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/a-2033-4891","volume":"149","author":"FM Verri","year":"2024","unstructured":"Verri\u00a0FM, Dallmeier\u00a0D, Kumlehn\u00a0B, Swoboda\u00a0W, Denkinger\u00a0M (2024) Notwendigkeit eines multidimensionalen Assessments bei Frailty [The need for a\u00a0multidimensional assessment in frail patients]. Dtsch Med Wochenschr 149(1-02):23\u201329. https:\/\/doi.org\/10.1055\/a-2033-4891","journal-title":"Dtsch Med Wochenschr"},{"issue":"6","key":"2056_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3238\/arztebl.m2024.0262","volume":"122","author":"B Kumlehn","year":"2025","unstructured":"Kumlehn\u00a0B, Brefka\u00a0S, Kocar\u00a0T, Verri\u00a0FM, Wirth\u00a0R, Denkinger\u00a0M (2025) Clinical Practice Guideline: Comprehensive Geriatric Assessment in the Hospital. Dtsch Arztebl Int 122(6):156\u2013162. https:\/\/doi.org\/10.3238\/arztebl.m2024.0262","journal-title":"Dtsch Arztebl Int"},{"issue":"17","key":"2056_CR19","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/1873-3468.14941","volume":"598","author":"MC Polidori","year":"2024","unstructured":"Polidori\u00a0MC (2024) Embracing complexity of (brain) aging. FEBS Lett 598(17):2067\u20132073. https:\/\/doi.org\/10.1002\/1873-3468.14941","journal-title":"FEBS Lett"},{"issue":"2","key":"2056_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1212\/WNL.0b013e3181e7f2ab","volume":"75","author":"NL Campbell","year":"2010","unstructured":"Campbell\u00a0NL, Boustani\u00a0MA, Lane\u00a0KA, Gao\u00a0S, Hendrie\u00a0H, Khan\u00a0BA et\u00a0al (2010) Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 75(2):152\u2013159","journal-title":"Neurology"},{"issue":"8","key":"2056_CR21","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox\u00a0C, Richardson\u00a0K, Maidment\u00a0ID, Savva\u00a0GM, Matthews\u00a0FE, Smithard\u00a0D et\u00a0al (2011) Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study. J\u00a0Am Geriatr Soc 59(8):1477\u20131483","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2056_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jamainternmed.2014.7667","volume":"175","author":"NL Campbell","year":"2015","unstructured":"Campbell\u00a0NL, Boustani\u00a0MA (2015) Adverse cognitive effects of medications: turning attention to reversibility. JAMA Intern Med 175(3):408\u2013409. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7667","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2056_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray\u00a0SL, Anderson\u00a0ML, Dublin\u00a0S, Hanlon\u00a0JT, Hubbard\u00a0R, Walker\u00a0R, Yu\u00a0O, Crane\u00a0PK, Larson\u00a0EB (2015) Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 175(3):401\u2013407. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663","journal-title":"JAMA Intern Med"},{"key":"2056_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5205","volume":"349","author":"S Billioti de Gage","year":"2014","unstructured":"Billioti de Gage\u00a0S, Moride\u00a0Y, Ducruet\u00a0T, Kurth\u00a0T, Verdoux\u00a0H, Tournier\u00a0M, Pariente\u00a0A, B\u00e9gaud\u00a0B (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. Can J Hosp Pharm 349:g5205. https:\/\/doi.org\/10.1136\/bmj.g5205","journal-title":"BMJ"},{"issue":"3","key":"2056_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s11096-024-01861-4","volume":"47","author":"AE Weidmann","year":"2025","unstructured":"Weidmann\u00a0AE, Propp\u00e9\u00a0GB, Matth\u00edasd\u00f3ttir\u00a0R, Tadi\u0107\u00a0I, Gunnarsson\u00a0PS, J\u00f3nsd\u00f3ttir\u00a0F (2025) Medication-induced causes of delirium in patients with and without dementia: a systematic review of published neurology guidelines. Int J Clin Pharm 47(3):606\u2013623. https:\/\/doi.org\/10.1007\/s11096-024-01861-4","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"2056_CR26","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel (2023) American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J\u00a0Am Geriatr Soc 71(7):2052\u20132081. https:\/\/doi.org\/10.1111\/jgs.18372","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"2056_CR27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s00108-012-3125-3","volume":"53","author":"M Wehling","year":"2012","unstructured":"Wehling\u00a0M (2012) Medikation im Alter : Kognitionseinschr\u00e4nkende Pharmaka [Medication in the elderly : cognitive impairment by drugs]. Inn Med 53(10):1240\u20131247. https:\/\/doi.org\/10.1007\/s00108-012-3125-3","journal-title":"Internist (Berl)"},{"issue":"4","key":"2056_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/1060028020949125","volume":"55","author":"AS Zaidi","year":"2021","unstructured":"Zaidi\u00a0AS, Peterson\u00a0GM, Bereznicki\u00a0LRE, Curtain\u00a0CM, Salahudeen\u00a0M (2021) Outcomes of Medication Misadventure Among People With Cognitive Impairment or Dementia: A Systematic Review and Meta-analysis. Ann Pharmacother 55(4):530\u2013542. https:\/\/doi.org\/10.1177\/1060028020949125","journal-title":"Ann Pharmacother"},{"issue":"11","key":"2056_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/0115672050289946240223050737","volume":"20","author":"Z Khan","year":"2024","unstructured":"Khan\u00a0Z, Mehan\u00a0S, Saifi\u00a0MA, Gupta\u00a0GD, Narula\u00a0AS, Kalfin\u00a0R (2024) Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks. Curr Alzheimer Res 20(11):739\u2013757. https:\/\/doi.org\/10.2174\/0115672050289946240223050737","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"2056_CR30","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s41999-025-01201-3","volume":"16","author":"AS Doherty","year":"2025","unstructured":"Doherty\u00a0AS, Moriarty\u00a0F, Boland\u00a0F, Clyne\u00a0B, Fahey\u00a0T, Kenny\u00a0RA, O\u2019Mahony\u00a0D, Wallace\u00a0E (2025) Prevalence of potentially inappropriate prescribing in community-dwelling older adults: an application of STOPP\/START version 3 to The Irish Longitudinal Study on Ageing (TILDA). Eur Geriatr Med 16(4):1389\u20131402. https:\/\/doi.org\/10.1007\/s41999-025-01201-3","journal-title":"Eur Geriatr Med"},{"issue":"12","key":"2056_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s40266-025-01257-7","volume":"42","author":"F Pazan","year":"2025","unstructured":"Pazan\u00a0F, Weiss\u00a0C, Wehling\u00a0M, FORTA (2025) The FORTA (Fit for the Aged) List 2024: Fifth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults. Drugs Aging 42(12):1197\u20131199. https:\/\/doi.org\/10.1007\/s40266-025-01257-7","journal-title":"Drugs Aging"},{"issue":"9","key":"2056_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2025.100763","volume":"6","author":"M Izquierdo","year":"2025","unstructured":"Izquierdo\u00a0M, Ram\u00edrez-V\u00e9lez\u00a0R, Fiatarone Singh\u00a0MA (2025) Integrating exercise and medication management in geriatric care: a\u00a0holistic strategy to enhance health outcomes and reduce polypharmacy. Lancet Healthy Longev 6(9):100763. https:\/\/doi.org\/10.1016\/j.lanhl.2025.100763","journal-title":"Lancet Healthy Longev"},{"issue":"9","key":"2056_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac205","volume":"51","author":"M Montero-Odasso","year":"2022","unstructured":"Montero-Odasso\u00a0M, van der Velde\u00a0N, Martin\u00a0FC, Petrovic\u00a0M, Tan\u00a0MP, Ryg\u00a0J, Aguilar-Navarro\u00a0S, Alexander\u00a0NB, Becker\u00a0C, Blain\u00a0H, Bourke\u00a0R, Cameron\u00a0ID, Camicioli\u00a0R, Clemson\u00a0L, Close\u00a0J, Delbaere\u00a0K, Duan\u00a0L, Duque\u00a0G, Dyer\u00a0SM, Freiberger\u00a0E, Ganz\u00a0DA, G\u00f3mez\u00a0F, Hausdorff\u00a0JM, Hogan\u00a0DB, Hunter\u00a0SMW, Jauregui\u00a0JR, Kamkar\u00a0N, Kenny\u00a0RA, Lamb\u00a0SE, Latham\u00a0NK, Lipsitz\u00a0LA, Liu-Ambrose\u00a0T, Logan\u00a0P, Lord\u00a0SR, Mallet\u00a0L, Marsh\u00a0D, Milisen\u00a0K, Moctezuma-Gallegos\u00a0R, Morris\u00a0ME, Nieuwboer\u00a0A, Perracini\u00a0MR, Pieruccini-Faria\u00a0F, Pighills\u00a0A, Said\u00a0C, Sejdic\u00a0E, Sherrington\u00a0C, Skelton\u00a0DA, Dsouza\u00a0S, Speechley\u00a0M, Stark\u00a0S, Todd\u00a0C, Troen\u00a0BR, van der Cammen\u00a0T, Verghese\u00a0J, Vlaeyen\u00a0E, Watt\u00a0JA, Masud\u00a0T, Task Force on Global Guidelines for Falls in Older Adults (2022) World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing 51(9):afac205. https:\/\/doi.org\/10.1093\/ageing\/afac205","journal-title":"Age Ageing"},{"key":"2056_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s41999-023-00824-8","volume":"14","author":"N van der Velde","year":"2023","unstructured":"van der Velde\u00a0N, Seppala\u00a0LJ, Hartikainen\u00a0S et\u00a0al (2023) European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation. Eur Geriatr Med 14:649\u2013658. https:\/\/doi.org\/10.1007\/s41999-023-00824-8","journal-title":"Eur Geriatr Med"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02056-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:03:19Z","timestamp":1771880599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02056-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2056"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02056-x","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.C.\u00a0Polidori und C.\u00a0Sieber geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}